Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Shenlingcao Oral Liquid in Stage II/IIIA NSCLC
NCT03712969Phase 4Completed
- Sponsor
- West China Hospital of Sichuan University
- Start
- Nov 2018
- Primary completion
- Mar 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of shenlingcao in non-small cell lung cancer (NSCLC), sponsored by West China Hospital of Sichuan University. Started Nov 2018; status: completed.
02
Drugs
shenlingcao
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on NCT03712969.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03712969.